Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
U.S. Bancorp heads into its October 15 Q3 earnings with analyst sentiment broadly constructive but price targets moving in one direction: lower.
The most telling signal heading into the print is the analyst tape. The Street has trimmed targets across the board over the past two weeks, with JP Morgan cutting to $65 from $69, Evercore ISI dropping to $65 from $72, and Truist lowering to $67 from $69, all while keeping positive ratings intact. TD Cowen reinstated coverage on October 8 with a Buy and a $70 target, a partial offset, and HSBC raised its target to $76 before the wave of cuts arrived. The consensus sits at a mean target of $69.00 against a current price of $57.08, implying roughly 21% upside, but the direction of travel this month has been unanimously downward. The stock has reflected that adjustment: it is down nearly 9% over the past month, outpacing its regional banking peers to the downside, with , , and each posting weekly declines of under 1.2%.
The bull and bear cases are not far apart on the bank's operational picture. Bulls point to second-quarter record net revenue of $7.7 billion, diluted EPS of $1.35, and an ROTCE of 18.7%, alongside 400 basis points of positive operating leverage and a CET1 ratio of 10.8%. Bears flag the other side of that same ledger: noninterest expense ran to $4.43 billion, management still expects roughly $160 million of additional reserves tied to the Amazon Small Business credit card portfolio, and any macro deterioration would put pressure on provisions that are already drawing attention. The anxiety about recession risk in 2027, rising from persistent inflation and policy uncertainty, gives the bear case its backbone even if current credit metrics look manageable.
Short sellers are not pressing the thesis in a meaningful way. Short interest has been unwinding, falling 8.4% over the past week to about 1.55% of the free float, a low reading that reflects no particular conviction among bears in the lending market. Borrow costs are minimal at 0.29% and availability is essentially unconstrained, meaning there is no squeeze dynamic in play. Options positioning is equally subdued: the put/call ratio is 0.69, fractionally below its 20-day average and nowhere near the defensive extremes seen earlier in the year. The ORTEX short score of 31.9 corroborates the picture, placing USB firmly in the lower half of the short-pressure universe.
FDIC call report data published by the Federal Deposit Insurance Corporation offers one factual backdrop worth noting. Net loans and leases have risen for four consecutive quarters, reaching $405.7 billion as of the April 2026 period. Total assets set a record for Q2 at $705.6 billion. The call report dataset has not been tested as a lead indicator against USB's reported quarterly figures, so it carries no predictive weight for the print, but it does confirm that the balance sheet trajectory heading into the result has been one of consistent growth.
The October 15 print will ultimately test whether USB's operational momentum from Q2, particularly loan growth and fee diversification, held through a quarter in which the macro backdrop turned more uncertain and the stock itself gave back a meaningful portion of its year-to-date gains.
See the live data behind this article on ORTEX.
Open USB on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
